GRC-17536

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGRC-17536
Drug Alias NameGRC 17536 potassium powder for inhalation - Glenmark PharmaceuticalsGRC-17536ISC 17536ISC-17536
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily A member 1 inhibitors
TargetsTransient receptor potential cation channel subfamily A member 1
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlenmark Pharmaceuticals SaGlenmark Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A